ArticleCancer discovery2022

Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance.

Zhentao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.